BAROSTIM THERAPY™ 2020
BAROSTIM NEO™ is helping the 59% of systolic heart failure patients—who have been living with an unmet need
Patient Story
See how we helped Dave get back to doing what he loves
BAROSTIM THERAPY™
Helping patients with their heart failure symptoms
CVRx® Receives FDA Approval for World’s First Heart Failure Neuromodulation Device
Discover BAROSTIM NEO™
CVRx® developed a proprietary implantable technology for the treatment of heart failure and high blood pressure. BAROSTIM NEO™ uses CVRx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. BAROSTIM NEO™ can be adjusted to meet each patient’s individual therapy needs.
Learn More
